Kiyoshi Fukuhara Selected Research

rubiadin

5/2012	Determination of lucidin-specific DNA adducts by liquid chromatography with tandem mass spectrometry in the livers and kidneys of rats given lucidin-3-O-primeveroside.
1/2010	Chemical structure determination of DNA bases modified by active metabolites of lucidin-3-O-primeveroside.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kiyoshi Fukuhara Research Topics

Disease

4	Alzheimer Disease (Alzheimer's Disease) 09/2020 - 03/2013
4	Carcinogenesis 05/2012 - 12/2004
3	Neoplasms (Cancer) 06/2007 - 09/2005
2	Obesity 02/2019 - 01/2013
2	Arteriosclerosis 11/2017 - 01/2017
2	Colonic Neoplasms (Colon Cancer) 04/2011 - 04/2011
2	Chromosome Aberrations (Chromosome Abnormalities) 02/2008 - 11/2002
1	Atherosclerotic Plaque (Atheroma) 10/2020
1	Allergic Contact Dermatitis 02/2019
1	Contact Dermatitis (Eczema, Contact) 02/2019
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2017
1	Stroke (Strokes) 01/2015
1	Dementia (Dementias) 03/2013
1	Neurodegenerative Diseases (Neurodegenerative Disease) 03/2013
1	Type 2 Diabetes Mellitus (MODY) 01/2013
1	Insulin Resistance 01/2013
1	Necrosis 01/2011
1	Parkinson Disease (Parkinson's Disease) 01/2009
1	Neuroblastoma 01/2009

Drug/Important Bio-Agent (IBA)

5	ResveratrolIBA 01/2015 - 11/2002
4	AntioxidantsIBA 09/2020 - 03/2006
3	oxidized low density lipoproteinIBA 10/2020 - 01/2017
2	Catechin (Z 7300)IBA 02/2019 - 01/2017
2	LectinsIBA 11/2017 - 01/2017
2	Amyloid (Amyloid Fibrils)IBA 11/2016 - 01/2016
2	rubiadinIBA 05/2012 - 01/2010
2	lucidinIBA 05/2012 - 01/2010
2	DNA (Deoxyribonucleic Acid)IBA 04/2011 - 01/2010
2	Coloring Agents (Dyes)IBA 04/2011 - 04/2011
2	AnthraquinonesIBA 01/2010 - 06/2007
1	HDL LipoproteinsIBA 10/2020
1	milk-thistle extractIBA 09/2020
1	Silybin (Lagosa)IBA 09/2020
1	Biological ProductsIBA 09/2020
1	HaptensIBA 02/2019
1	DinitrofluorobenzeneIBA 02/2019
1	Proanthocyanidins (Procyanidins)IBA 11/2017
1	Oxidized LDL ReceptorsIBA 11/2017
1	proanthocyanidinIBA 01/2017
1	6- hydroxy- 2,5,7,8- tetramethylchroman- 2- carboxylic acid (Trolox)IBA 01/2016
1	Protein AggregatesIBA 01/2016
1	Peptides (Polypeptides)IBA 01/2016
1	Biomarkers (Surrogate Marker)IBA 03/2013
1	AllantoinIBA 03/2013
1	3-hydroxykynurenineIBA 03/2013
1	Glucose (Dextrose)FDA LinkGeneric 01/2013
1	StilbenesIBA 01/2013
1	hydroxide ionIBA 01/2013
1	SulfotransferasesIBA 04/2011
1	mitotracker green FMIBA 04/2011
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 04/2011
1	Analgesics (Analgesic Drugs)IBA 01/2011
1	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2011
1	Pharmaceutical PreparationsIBA 01/2011
1	AntipyreticsIBA 01/2011
1	Caspase 3 (Caspase-3)IBA 01/2009
1	1,2,3,4-tetrahydroisoquinolineIBA 01/2009
1	NeurotoxinsIBA 01/2009
1	norsalsolinolIBA 01/2009
1	Cytochromes c (Cytochrome c)IBA 01/2009
1	9-nitroanthraceneIBA 06/2007
1	PolyphenolsIBA 03/2006
1	Salicylic Acid (2 Hydroxybenzoic Acid)FDA LinkGeneric 09/2005
1	Antineoplastic Agents (Antineoplastics)IBA 09/2005
1	Hydroxyl RadicalIBA 09/2005
1	pyridine N-oxideIBA 09/2005
1	GentisatesIBA 09/2005
1	catechol (pyrocatechol)IBA 09/2005
1	1-benzyl-1,4-dihydronicotinamideIBA 09/2005
1	DNA AdductsIBA 12/2004

Therapy/Procedure

1	Therapeutics 06/2007